Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 11;17(6):765.
doi: 10.3390/ph17060765.

Efficacy and Safety of Remdesivir in Adult Solid Organ Transplant Recipients: A Scoping Review

Catherine Smith  1 , Maria Eugenia Novara  2 , Andrea Cona  3 , Anna Dolcimascolo  4 , Giulia Cancellieri  4 , Francesca Mortillaro  4 , Enrico Ottavio Giannini  4 , Anna Carollo  2 , Alessandra Mularoni  3 , Alessio Provenzani  2
Affiliations

Efficacy and Safety of Remdesivir in Adult Solid Organ Transplant Recipients: A Scoping Review

Catherine Smith et al. Pharmaceuticals (Basel). .

Abstract

The SARS-CoV-2 infection has been associated with important mortality, particularly in immunocompromised patients, including solid organ transplant (SOT) recipients. Remdesivir (RDV) is an antiviral drug that has proven to be effective in reducing the replication of the virus in host cells, by which it may reduce the progression of symptoms and, consequently, the length of hospital stay and mortality. Randomized controlled trials have evaluated its use in the general population but never in SOT recipients. For the first time in this review, the safety and efficacy of RDV is evaluated in this specific population. The literature research was conducted using PubMed/MEDLINE and Scopus databases from 1 January 2020 to 24 November 2023, and 23 studies were analyzed. Although no clinical studies specifically evaluating this population have been conducted yet, RDV is likely safe for SOT patients when compared to the general population, so prescribers should consider utilizing RDV in SOT patients who are at high risk for progression to severe COVID-19. Future research will allow for the confirmation of the observed results and the acquisition of broader and clearer data regarding the safety and efficacy of the drug in this specific setting.

Keywords: COVID-19; SARS-CoV-2; efficacy; remdesivir; safety; solid organ transplant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram. RDV = remdesivir; SOT = solid organ transplant.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Black C.K., Termanini K.M., Aguirre O., Hawksworth J.S., Sosin M. Solid organ transplantation in the 21st century. Ann. Transl. Med. 2018;6:409. doi: 10.21037/atm.2018.09.68. - DOI - PMC - PubMed
    1. Ravanan R., Callaghan C.J., Mumford L., Ushiro-Lumb I., Thorburn D., Casey J., Friend P., Parameshwar J., Currie I., Burnapp L., et al. SARS-CoV-2 infection and early mortality of waitlisted and solid organ transplant recipients in England: A national cohort study. Am. J. Transplant. 2020;20:3008–3018. doi: 10.1111/ajt.16247. - DOI - PMC - PubMed
    1. Arya A., Li M., Aburjania N., Singh P., Royer T., Moss S., Belden K.A. COVID-19 in solid organ transplantation: Disease severity and clinical update. Transplant. Proc. 2021;53:1227–1236. doi: 10.1016/j.transproceed.2021.02.014. - DOI - PMC - PubMed
    1. Trapani S., Masiero L., Puoti F., Rota M.C., Del Manso M., Lombardini L., Riccardo F., Amoroso A., Pezzotti P., Grossi P.A., et al. Incidence and outcome of SARS-CoV-2 infection on solid organ transplantation recipients: A nationwide population-based study. Am. J. Transplant. 2021;21:2509–2521. doi: 10.1111/ajt.16428. - DOI - PMC - PubMed
    1. Ge E., Li Y., Wu S., Candido E., Wei X. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS ONE. 2021;16:e0258154. doi: 10.1371/journal.pone.0258154. - DOI - PMC - PubMed

Publication types

LinkOut - more resources